Firms Seek Fees For Biogen's 'Egregious' Tactics In Docs Suit
Heyman Enerio Gattuso & Hirzel and Pomerantz told the Delaware Chancery Court on Tuesday that Biogen Inc. should have to pay them fees because the company employed 'glaringly egregious' tactics aimed...To view the full article, register now.
Already a subscriber? Click here to view full article